NCT07221838 2026-04-09
OCTAGON
Alexion Pharmaceuticals, Inc.
Phase 4 Recruiting
Clinical Trials
7 trialsNCT07246564 2026-03-27
Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis
UCB Pharma
Phase 4 Recruiting
NCT07072988 2025-09-24
OPTIMAGE
Centre Hospitalier Universitaire de Nice
Phase 4 Recruiting
NCT06723548 2024-12-09
Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis
First Affiliated Hospital of Wenzhou Medical University
Phase 4 Not yet recruiting
NCT03510546 2018-04-27
Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis
University of Aarhus
Phase 4 Unknown
NCT00987116 2017-10-13
MYACOR
Assistance Publique - Hôpitaux de Paris
Phase 4 Completed
NCT01179893 2010-08-11
Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis
University Health Network, Toronto
Phase 4 Completed